Therefore, we have focused on miRNAs targeting iR and Foxp1 gene expression in CD8+ T cells in murine 4T1 breast cancer cells in vitro; our data reveal that an miRNA has the capacity to enhance antitumour immunity by reversing CD8+ T-cell exhaustion. Here, CD8A is linked to breast cancer.